800
Participants
Start Date
June 17, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
May 23, 2016
TAS-102
35 mg/m2/dose, orally, twice daily on days 1-5 and 8-12 of each 28-day cycle. Number of cycles: until at least one of the discontinuation criteria are met.
Placebo
Placebo tablets, orally, twice daily on days 1-5 and 8-12 of each 28-day cycle. Number of cycles: until at least one of the discontinuation criteria are met.
St. Vincent's University Hospital, Dublin
Adelaide and Meath Hospital, Dublin
Universitaet Wien, Vienna
Universitaetsklinik fur Innere Medizin, Vienna
Wilhelminenspital Wien, Vienna
Cliniques Universitaires UCL St. Luc, Brussels
Universitatsklinikum Carl Gustav Carus - Dresden, Dresden
Royal North Shore Hospital, Sydney
Antwerp University Hospital, Edegem
University Hospital Gent, Edegem
Leuven University Hospital - Campus Gasthuiseberg, Leuven
University Hospital Gasthuisberg, Leuven
The Royal Melbourne Hospital, Parkville
Austin Hospital, Heidelberg
Krankenhaus der Barmherzigen Schwestern Linz, Linz
Klinikum Wels-Grieskirchen GmbH, Wels
The Queen Elisabeth Hospital, Woodville South
Grand Hospital de Charleroi, Charleroi
Sir Charles Gairdner Hospital, Perth
Uniklinik der Martin-Luther-Universitaet Halle-Wittenberg, Halle
Hospital Universitario Vall d'Hebrón, Barcelona
Corporacion Sanitaria Parc Tauli, Sabadell
University Hospital Gent, Ghent
Onkologische Schwerpunktpraxis Kurfuerstendamm, Berlin
"Universita Delgi Studi de Genova (UNIGE)- Azienda Ospedaliera. Universitaria San Martino (Ospedale San Martino)", Genova
Karolinska University Hospital, Stockholm
Fondazione IRCCS Instituto Nazionale dei Tumori Milano, Milan
A.O. Ospedale Niguarda Ca' Granda, Milan
Universitätsklinikum Hamburg-Eppendorf, Hamburg
Hematology/Oncology Associates of Fredericksburg, Fredericksburg
Ospedale di Sondrio, Sondrio
CHU de Becançon, Besançon
Fondazione Poliambulanza, Brescia
Hospital Arnau de Vilanova, Lleida
Klinikum Oldenburg gGmbH, Oldenburg
Institute of Oncology and Rehabilitation Ples, Nová Ves pod Pleší
Hospital Universitario Ramon y Cajal, Madrid
Fundacion Jimenez Diaz - Universidad Autonoma de Madrid, Madrid
Hospital 12 de Octubre, Madrid
Hospital Carlos Haya, Málaga
Hospital Universitario Morales Messeguer, Murcia
MD Anderson Cancer Center Orlando, Orlando
University Hospital of Bordeaux, Bordeaux
CRLC Val d'Aurelle, Montpellier
Centre Eugene Marquis, Rennes
Hospital Universitario Virgen del Rocio, Seville
Arcispidale S Maria Nuova, Reggio Emilia
Hickman Cancer Center at Flower Hospital, Sylvania
Gabrail Cancer Center, Canton
Hospital Clínico Universitario de Valencia, Valencia
Hospital General Universitario de Valencia, Valencia
Indiana University Simon Cancer Center, Indianapolis
Ospedale di Rimini, Rimini
St. Joseph Mercy Hospital, Ann Arbor
Klinika onkologie a radioteraie, Facultni nemocnice Hradec Kralove, Hradec Králové
Uniklinik Koeln, Cologne
Praxiskooperation Bonn-Euskirchen-Rheinbach, Bonn
Johannes Gutenberg Universität Mainz, Mainz
Centre Oscar Lambret, Lille
Medizinische Klinik am Krankenhaus Nordwest GmbH, Frankfurt
Illinois Cancer Care, P.C., Peoria
Saint Luke's Cancer Institute, Kansas City
Interdisziplinaeres Tumorzentrum Mannheim, Mannheim
Mary Bird Perkins Cancer Center, Baton Rouge
Akademiska Sjukhuset, Uppsala
Hopital Saint Antoine, Paris
"A.O. R.N. A.Cardarelli", Naples
Seconda Universita degli Studi de Napoli, Napoli
Klinikum der Universität München - Großhadern, München
Staedtisches Klinikum Muenchen / Klinikum Neuperlach, München
Arizona Center for Cancer Care, Glendale
Universitaetsklinikum Ulm, Ulm
LAC and USC Medical Center, Los Angeles
USC Norris Comprehensive Cancer Center, Los Angeles
Coastal Integrative Cancer Care, San Luis Obispo
California Cancer Associates for Research and Excellence, Fresno
Pacific Hematology Oncology Associates, San Francisco
Ronald H. Yanagihara, MD, Gilroy
San Jose Medical Group, San Jose
AOU San Luidi di Orbassano, Orbassano
National Cancer Center Hospital, Chuo-ku
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku
Keio University Hospital, Shinjuku-ku
Kanagawa Cancer Center, Yokohama
Chiba Cancer Center, Chiba
National Cancer Center Hospital East, Kashiwa
Tsukuba University Hospital, Tsukuba
Jichi Medical University Hospital, Shimotsuke
Saitama Cancer Center, Kita-adachi-gun
Shizuoka Cancer Center, Sunto-gun
Aichi Cancer Center Hospital, Nagoya
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Osaka Medical College Hospital, Takatsuki
Kobe City Medical Center General Hospital, Kobe
Azienda Ospedaliero, Pisa
Tokushima University Hospital, Tokushima
National Hospital Organization Shikoku Cancer Center, Matsuyama
National Hospital Organization Kyushu Cancer Center, Fukuoka
Kumamoto University Hospital, Kumamoto
Yale Cancer Center, New Haven
Ochsner Clinic Fndtn, New Orleans
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Jefferson City Medical Group, Jefferson City
Dartmouth-Hitchcock Medical Center, Lebanon
Erasme University Hospital-ULB-Brussels, Brussels
Bon Secours Hospital, Cork
National Cancer Center Hospital East, Kashiwa
KKR Sapporo Medical Center TONAN-Hospital, Sapporo
Hokkaido University Hospital, Sapporo
Aberdeen Royal Infirmary, Aberdeen
University Hospitals Bristol NHS Foundation Trust, Bristol
St James' Institute of Oncology, Leeds
University College London Hospitals Foundation NHS Trust, London
The Royal Marsden NHS Foundation Trust, Surrey
Taiho Oncology, Inc.
INDUSTRY